Transaction details
Alignment Healthcare (NASDAQ:ALHC) announced that Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of common stock on March 4, 2026, for approximately $393,250. The trade was executed at a weighted-average price of $18.6216, with individual sale prices spanning from $18.47 to $18.89.
Following the sale, Wagner directly holds 148,687 shares of Alignment Healthcare. The disposition was carried out through a pre-established Rule 10b5-1 trading plan that Wagner adopted on November 21, 2025.
Market context
The company's shares are currently trading at $18.88 and Alignment Healthcare has a market capitalization of $3.86 billion. The stock has fallen roughly 7.5% over the past week.
According to InvestingPro analysis, ALHC appears undervalued at current levels based on Fair Value metrics.
Secondary offering and related terms
Alignment Healthcare also disclosed that a secondary offering of 13.2 million shares has been priced at $19.46 per share. The offering is led by an affiliate of General Atlantic, L.P., and the company clarified that it will not receive any proceeds from the sale. The offering is expected to close on March 4, 2026, subject to customary closing conditions, with J.P. Morgan acting as the underwriter.
Quarterly results and analyst response
The company reported strong fourth-quarter performance, with membership increasing by approximately 25% year-over-year and revenues rising by approximately 44.4%. Management reported a medical benefit ratio of 87.7% and an improvement in the selling, general, and administrative expense ratio of about 115 basis points to 9.7%.
Following the quarterly results, Raymond James reiterated a Strong Buy rating with a $27.00 price target. Piper Sandler maintained an Overweight rating and set a $30.00 price target, both citing that Alignment Healthcare's fourth-quarter 2025 performance surpassed expectations.
What the filing and results show
The insider sale followed a pre-arranged trading plan and left Wagner with a meaningful personal stake in the company. At the same time, the company is navigating a sizeable secondary offering led by an affiliate investor while reporting outsized membership and revenue growth in the fourth quarter. Market reaction in the week prior to the filing showed a modest pullback in the share price.
Note: The information above reflects disclosure statements and company-reported results as provided in the filings and official announcements referenced.